GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
40.73
-7.03 (-14.72%)
At close: Feb 21, 2025, 4:00 PM
40.15
-0.58 (-1.42%)
After-hours: Feb 21, 2025, 7:47 PM EST
GRAIL Revenue
In the year 2024, GRAIL had annual revenue of $125.60M with 34.90% growth. GRAIL had revenue of $38.25M in the quarter ending December 31, 2024, with 26.14% growth.
Revenue (ttm)
$125.60M
Revenue Growth
+34.90%
P/S Ratio
10.35
Revenue / Employee
$92,349
Employees
1,360
Market Cap
1.38B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
GRAL News
- 1 day ago - GRAIL to Present at TD Cowen 45th Annual Health Care Conference - PRNewsWire
- 1 day ago - GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 days ago - GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 10 days ago - GRAIL to Announce Fourth Quarter 2024 Financial Results - PRNewsWire
- 10 days ago - GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System - PRNewsWire
- 26 days ago - Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week - Investopedia
- 4 weeks ago - Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20% - Investopedia
- 5 weeks ago - Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology - PRNewsWire